Consensus guidelines for the design and implementation of clinical trials in ALS
- 31 October 1999
- journal article
- review article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 169 (1-2), 2-12
- https://doi.org/10.1016/s0022-510x(99)00209-9
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Toward earlier diagnosis of amyotrophic lateral sclerosisNeurology, 1998
- Effect of recombinant human insulin-like growth factor-I on progression of ALSNeurology, 1997
- The quest for unbiased research: Randomized clinical trials and the CONSORT reporting guidelinesAnnals of Neurology, 1997
- Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosisNeurology, 1996
- Dose-ranging study of riluzole in amyotrophic lateral sclerosisThe Lancet, 1996
- A double‐blind placebo‐controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosisNeurology, 1996
- A placebo‐controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosisAnnals of Neurology, 1996
- A Controlled Trial of Riluzole in Amyotrophic Lateral SclerosisNew England Journal of Medicine, 1994
- Amyotrophic lateral sclerosis: Part 1. Clinical features, pathology, and ethical issues in managementAnnals of Neurology, 1985
- Clinical Statistics in 515 Fatal Cases of Motor Neuron DiseaseNeuroepidemiology, 1984